Paradigm Biopharmaceuticals | PAR - Cost Of Sales

Stock Price
0.26
Daily Change
-0.01 -3.70%
Monthly
-21.21%
Yearly
-46.94%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD1.88K in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Avita Medical AUD 3.47M 1.19M Jun/2025
Medical Developments International AUD 2.18M 3.09M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025